Patents by Inventor Algirdas Jonas Kakarieka WEISSKOPF

Algirdas Jonas Kakarieka WEISSKOPF has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB
    Publication number: 20240150485
    Abstract: The disclosure is directed to treatment regimens for treating Multiple Sclerosis (MS).
    Type: Application
    Filed: June 8, 2023
    Publication date: May 9, 2024
    Inventors: Erik Wallström, Marina Savelieva Praz, Algirdas Jonas Kakarieka Weisskopf, Joseph Michael Kahn
  • REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB
    Publication number: 20220081488
    Abstract: The disclosure is directed to treatment regimens for treating Multiple Sclerosis (MS). These methods utilize administration of ofatumumab, an anti-CD20 monoclonal antibody, to the patient during a loading dose regimen and a maintenance regimen.
    Type: Application
    Filed: October 6, 2021
    Publication date: March 17, 2022
    Inventors: Erik Wallström, Marina Savelieva Praz, Algirdas Jonas Kakarieka Weisskopf, Joseph Michael Kahn
  • METHOD FOR TREATING MULTIPLE SCLEROSIS
    Publication number: 20210388099
    Abstract: The present invention concerns methods for treating multiple sclerosis (MS) in a patient, and an article of manufac-ture with instructions for such use.
    Type: Application
    Filed: March 16, 2021
    Publication date: December 16, 2021
    Inventors: David LEPPERT, Anne-Marie LI-KWAI-CHEUNG, Michele LIBONATI, Donna MASTERMAN, Jean-Paul PFEFEN, Craig SMITH, Algirdas Jonas Kakarieka WEISSKOPF, Jiameng ZHANG, Peter S. CHIN, Hideki GARREN
  • Regimens and methods of treating multiple sclerosis using ofatumumab
    Patent number: 11161909
    Abstract: The disclosure is directed to treatment regimens for treating Multiple Sclerosis (MS). These methods utilize administration of ofatumumab, an anti-CD20 monoclonal antibody, to the patient during a loading dose regimen and a maintenance regimen.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: November 2, 2021
    Assignee: NOVARTIS AG
    Inventors: Erik Wallström, Marina Savelieva Praz, Algirdas Jonas Kakarieka Weisskopf, Joseph Michael Kahn
  • REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB
    Publication number: 20190177424
    Abstract: The disclosure is directed to treatment regimens for treating Multiple Sclerosis (MS). These methods utilize administration of ofatumumab, an anti-CD20 monoclonal antibody, to the patient during a loading dose regimen and a maintenance regimen.
    Type: Application
    Filed: August 11, 2017
    Publication date: June 13, 2019
    Inventors: Erik Wallström, Marina Savelieva Praz, Algirdas Jonas Kakarieka Weisskopf, Joseph Michael Kahn
  • METHOD FOR TREATING MULTIPLE SCLEROSIS
    Publication number: 20180327505
    Abstract: The present invention concerns methods for treating multiple sclerosis (MS) in a patient, and an article of manufacture with instructions for such use.
    Type: Application
    Filed: April 5, 2018
    Publication date: November 15, 2018
    Inventors: David LEPPERT, Anne-Marie LI-KWAI-CHEUNG, Michele LIBONATI, Donna MASTERMAN, Jean-Paul PFEFEN, Craig SMITH, Algirdas Jonas Kakarieka WEISSKOPF, Jiameng ZHANG, Peter S. CHIN, Hideki GARREN